Drug Candidate for Chronic Cough Rejected by FDA Panel

Gefapixant's benefit not clinically meaningful enough, panelists say

Related Keywords

,Stacy Chin ,Division Of Pulmonology ,Allergy Drugs Advisory Committee ,Pulmonary Allergy Drugs Advisory Committee ,Leicester Cough Questionnaire ,